As financial savings and patient benefits, such as health insurance, are emerging as major issues both domestically and globally, biosimilars that have the same effect as the original and are cheaper are expanding their presence. In addition, a flood of biosimilars is predicted due to the expiration of patents for blockbuster treatments, and infinite competition … Read more
Amid the recent trend of increasing patients with benign prostatic hyperplasia due to the aging population, the related treatment market is also excited. Among them, ‘Saw Palmetto Extract (Serenoa repens)’ is attracting attention again. In the clinical field, it has already been recognized for its therapeutic effect in Europe, etc. According to the pharmaceutical industry … Read more
A study has found that being infected with the coronavirus during pregnancy increases the risk of neurodevelopment, such as autism spectrum disorder, in a child born. These effects were particularly concentrated in male children, and experts say that long follow-up measures are needed for pregnant women and children who have been infected with the corona. … Read more
In 2023, the standard vaccination strategy for children and adolescents was updated. The human papillomavirus vaccine (HPV) was changed from the age of 12 to 11, and the interval between vaccinations for the Japanese encephalitis vaccine also changed. On the 24th, the Korean Vaccine Society held the 21st Spring Conference at L Convention and shared … Read more
Biktarvy product photo Five-year long-term data of the HIV-1 drug Biktarvy (ingredient name bictegravir/emtricitabine/tenofovir alafenamide, B/F/TAF) was added to the approval requirements. Gilead Sciences Korea announced on the 27th that the Ministry of Food and Drug Safety on January 30th added clinical information on 5-year long-term data conducted on adults infected with HIV-1 after initial … Read more
Lee Han-ah, planning committee member of the Liver Cancer Association (Division of Gastroenterology, Ewha Womans University Mok-dong Hospital) While the number of elderly patients with liver cancer is increasing, a study has found that the prognosis during treatment intervention is similar to that of non-elderly patients. In particular, in the case of advanced liver cancer … Read more
Cancer, not cardiovascular disease, is the leading cause of death in type 2 diabetes, a new study has found. This breaks the conventional wisdom that the cause of death in diabetes is a cardiovascular disease complication, suggesting the need for a multidisciplinary approach. The results of a study on the mortality rate of patients with … Read more
Daewoong Pharmaceutical announced that Enblo Tab. was announced as a successful case of rapid product development at the ‘Innovative Pharmaceutical Company GIFT Rapid Review Support Conference’ co-hosted by the Rapid Review Division of the Food and Drug Safety Evaluation Institute and the Korea Pharmaceutical Bio Association at 3:00 pm on the 26th. . An innovative … Read more
The side effect issue of diabetic retinopathy (DR) of type 2 diabetes treatment glucagon-like peptide-1 receptor agonist (GLP-1 RA) has been reconfirmed. At the time of the development of semaglutide, an increase in retinopathy patients was observed in clinical trials, but as a similar trend was found in a meta-analysis involving a total of 60,000 … Read more
Studies have shown that high-density lipoprotein (HDL-C), the cholesterol that is good for cardiovascular health, is negative for bone health. For cardiovascular health, high HDL-C is good, but for bone health, it means you need to find the right trade-off. The results of a study on the association between plasma HDL-C levels and fracture risk, … Read more